Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review.

Iskandar, Rowan; Taghavi, Katayoun; Low, Nicola; Bramer, Wichor M; Egger, Matthias; Rohner, Eliane (2022). Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review. Value in health regional issues, 32, pp. 39-46. Elsevier 10.1016/j.vhri.2022.07.001

[img]
Preview
Text
1-s2.0-S2212109922001327-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

OBJECTIVES

Mathematical modeling is increasingly used to inform cervical cancer control policies, and model-based evaluations of such policies in women living with human immunodeficiency virus (HIV) are an emerging research area. We did a scoping review of published literature to identify research gaps and inform future work in this field.

METHODS

We systematically searched literature up to April 2022 and included mathematical modeling studies evaluating the effectiveness or cost-effectiveness of cervical cancer prevention strategies in populations including women living with HIV. We extracted information on prevention strategies and modeling approaches.

RESULTS

We screened 1504 records and included 22 studies, almost half of which focused on South Africa. We found substantial between-study heterogeneity in terms of strategies assessed and modeling approaches used. Fourteen studies evaluated cervical cancer screening strategies, 7 studies assessed human papillomavirus vaccination (with or without screening), and 1 study evaluated the impact of HIV control measures on cervical cancer incidence and mortality. Thirteen conducted cost-effectiveness analyses. Markov cohort state-transition models were used most commonly (n = 12). Most studies (n = 17) modeled the effect of HIV by creating HIV-related health states. Thirteen studies performed model calibration, but 11 did not report the calibration methods used. Only 1 study stated that model code was available upon request.

CONCLUSIONS

Few model-based evaluations of cervical cancer control strategies have specifically considered women living with HIV. Improvements in model transparency, by sharing information and making model code publicly available, could facilitate the utility of these evaluations for other high disease-burden countries, where they are needed for assisting policy makers.

Item Type:

Journal Article (Review Article)

Division/Institute:

?? DBE850B67E4A425FAA5C391339CAC35C ??
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Iskandar, Rowan, Taghavi, Katayoun, Low, Nicola, Egger, Matthias, Rohner, Eliane

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

2212-1102

Publisher:

Elsevier

Funders:

[4] Swiss National Science Foundation ; [211] NIH National Institute of Allergy and Infectious Diseases

Language:

English

Submitter:

Pubmed Import

Date Deposited:

07 Sep 2022 14:23

Last Modified:

05 Dec 2022 16:23

Publisher DOI:

10.1016/j.vhri.2022.07.001

PubMed ID:

36063639

Uncontrolled Keywords:

HIV HPV cervical cancer comparative effectiveness cost-effectiveness modeling prevention screening vaccination

BORIS DOI:

10.48350/172725

URI:

https://boris.unibe.ch/id/eprint/172725

Actions (login required)

Edit item Edit item
Provide Feedback